Royal Bank of Canada »

Pasithea Therapeutics Corp shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTA) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Pasithea Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 250 4.00
2024-06-30 $1.0k 250 4.00
2024-03-31 $2.0k 250 8.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Pasithea Therapeutics Corp

Tower Research Capital
Royal Bank of Canada
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Pasithea Therapeutics Corp